Drug Patents owned by Wyeth Pharms

1. List of Duavee drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7683051 WYETH PHARMS Crystalline polymorph of bazedoxifene acetate
Mar, 2027

(4 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6479535 WYETH PHARMS 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
May, 2024

(1 year, 3 months from now)

Drugs and Companies using BAZEDOXIFENE ACETATE; ESTROGENS, CONJUGATED ingredient

Market Authorisation Date: 03 October, 2013

Treatment: Prevention of postmenopausal osteoporosis; Treatment of moderate to severe vasomotor symptoms associated with menopause

Dosage: TABLET;ORAL

More Information on Dosage

2. List of Protonix drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7553498 WYETH PHARMS Pantoprazole multiparticulate formulations
Sep, 2024

(1 year, 7 months from now)

US7550153 WYETH PHARMS Pantoprazole multiparticulate formulations
Sep, 2024

(1 year, 7 months from now)

US7838027 WYETH PHARMS Pantoprazole multiparticulate formulations
Sep, 2024

(1 year, 7 months from now)

US7550153

(Pediatric)

WYETH PHARMS Pantoprazole multiparticulate formulations
Mar, 2025

(2 years from now)

US7838027

(Pediatric)

WYETH PHARMS Pantoprazole multiparticulate formulations
Mar, 2025

(2 years from now)

US7553498

(Pediatric)

WYETH PHARMS Pantoprazole multiparticulate formulations
Mar, 2025

(2 years from now)

US7544370 WYETH PHARMS Pantoprazole multiparticulate formulations
Jun, 2026

(3 years from now)

US7544370

(Pediatric)

WYETH PHARMS Pantoprazole multiparticulate formulations
Dec, 2026

(3 years from now)

Drugs and Companies using PANTOPRAZOLE SODIUM ingredient

Market Authorisation Date: 14 November, 2007

Treatment: Erosive esophagitis, hypersecretory conditions including zollinger-ellison syndrome, maintenance of healing of erosive esophagitis and reduction of symptoms in patients with gerd

Dosage: FOR SUSPENSION, DELAYED RELEASE;ORAL

How can I launch a generic of PROTONIX before it's patent expiration?
More Information on Dosage

3. List of Protonix Iv drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8754108

(Pediatric)

WYETH PHARMS Freeze-dried pantoprazole preparation and pantoprazole injection
May, 2022

(8 months ago)

US6780881

(Pediatric)

WYETH PHARMS Freeze-dried pantoprazole preparation and pantoprazole injection
May, 2022

(8 months ago)

US7351723

(Pediatric)

WYETH PHARMS Freeze-dried pantoprazole preparation and pantoprazole injection
May, 2022

(8 months ago)

Drugs and Companies using PANTOPRAZOLE SODIUM ingredient

Market Authorisation Date: 22 March, 2001

Treatment: NA

Dosage: INJECTABLE;INTRAVENOUS

How can I launch a generic of PROTONIX IV before it's patent expiration?
More Information on Dosage

4. List of Zosyn drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6900184 WYETH PHARMS Compositions containing pipercillin and tazobactam useful for injection
Apr, 2023

(2 months from now)

US7915229 WYETH PHARMS Compositions containing piperacillin and tazobactam useful for injection
Apr, 2023

(2 months from now)

US8133883 WYETH PHARMS Compositions containing piperacillin and tazobactam useful for injection
Apr, 2023

(2 months from now)

Drugs and Companies using PIPERACILLIN SODIUM; TAZOBACTAM SODIUM ingredient

Market Authorisation Date: 22 October, 1993

Treatment: Method of treating bacterial infections

Dosage: INJECTABLE;INJECTION

How can I launch a generic of ZOSYN before it's patent expiration?
More Information on Dosage

5. List of Zosyn In Plastic Container drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6900184 WYETH PHARMS Compositions containing pipercillin and tazobactam useful for injection
Apr, 2023

(2 months from now)

US7915229 WYETH PHARMS Compositions containing piperacillin and tazobactam useful for injection
Apr, 2023

(2 months from now)

US8133883 WYETH PHARMS Compositions containing piperacillin and tazobactam useful for injection
Apr, 2023

(2 months from now)

Drugs and Companies using PIPERACILLIN SODIUM; TAZOBACTAM SODIUM ingredient

Market Authorisation Date: 24 February, 1998

Treatment: Method of treating bacterial infections

Dosage: INJECTABLE;INJECTION

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in